✦ LIBER ✦

[Current Topics in Microbiology and Immunology] Phosphoinositide 3-kinase in Health and Disease Volume 346 || PI3 Kinase Regulation of Skeletal Muscle Hypertrophy and Atrophy

✍ Scribed by Rommel, Christian; Vanhaesebroeck, Bart; Vogt, Peter K.

Book ID: 118239395
Publisher: Springer Berlin Heidelberg
Year: 2010
Weight: 198 KB
Category: Article
ISBN: 364213663X
DOI: 10.1007/82_2010_78

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

[Current Topics in Microbiology and Immu

[Current Topics in Microbiology and Immunology] Phosphoinositide 3-kinase in Health and Disease Volume 346 || Role of RAS in the Regulation of PI 3-Kinase

✍ Rommel, Christian; Vanhaesebroeck, Bart; Vogt, Peter K. 📂 Article 📅 2010 🏛 Springer Berlin Heidelberg ⚖ 350 KB

[Current Topics in Microbiology and Immu

[Current Topics in Microbiology and Immunology] Phosphoinositide 3-kinase in Health and Disease Volume 346 || PDK1: The Major Transducer of PI 3-Kinase Actions

✍ Rommel, Christian; Vanhaesebroeck, Bart; Vogt, Peter K. 📂 Article 📅 2010 🏛 Springer Berlin Heidelberg ⚖ 245 KB

[Current Topics in Microbiology and Immu

[Current Topics in Microbiology and Immunology] Phosphoinositide 3-kinase in Health and Disease Volume 346 || Protein Kinase B (PKB/Akt), a Key Mediator of the PI3K Signaling Pathway

✍ Rommel, Christian; Vanhaesebroeck, Bart; Vogt, Peter K. 📂 Article 📅 2010 🏛 Springer Berlin Heidelberg ⚖ 324 KB

[Current Topics in Microbiology and Immu

[Current Topics in Microbiology and Immunology] Phosphoinositide 3-kinase in Health and Disease Volume 347 || From the Bench to the Bed Side: PI3K Pathway Inhibitors in Clinical Development

✍ Rommel, Christian; Vanhaesebroeck, Bart; Vogt, Peter K. 📂 Article 📅 2010 🏛 Springer Berlin Heidelberg 🌐 German ⚖ 377 KB

PI3K has become a very intense area of research, with over 2000 publications on PI3K in PubMed for 2009 alone. The expectations for a therapeutic impact of intervention with PI3K activity are high, and progress in the clinical arena is being monitored by many. However, targeted therapies almost inva